Heart Current Deferred Revenue from 2010 to 2025
| HSCSW Stock | USD 0.04 0.01 17.92% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 767.2 K | Current Value 563.6 K | Quarterly Volatility 152 K |
Check Heart Test financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heart Test's main balance sheet or income statement drivers, such as Depreciation And Amortization of 58.5 K, Interest Expense of 242.9 K or Selling General Administrative of 2.5 M, as well as many indicators such as Price To Sales Ratio of 150, Dividend Yield of 0.0 or PTB Ratio of 0.49. Heart financial statements analysis is a perfect complement when working with Heart Test Valuation or Volatility modules.
Heart | Current Deferred Revenue |
Latest Heart Test's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Heart Test Laboratories over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Heart Test's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heart Test's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Heart Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 440,109 | |
| Geometric Mean | 419,151 | |
| Coefficient Of Variation | 34.53 | |
| Mean Deviation | 130,519 | |
| Median | 337,589 | |
| Standard Deviation | 151,971 | |
| Sample Variance | 23.1B | |
| Range | 429.6K | |
| R-Value | 0.81 | |
| Mean Square Error | 8.5B | |
| R-Squared | 0.66 | |
| Significance | 0.0001 | |
| Slope | 25,868 | |
| Total Sum of Squares | 346.4B |
Heart Current Deferred Revenue History
About Heart Test Financial Statements
Heart Test investors use historical fundamental indicators, such as Heart Test's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Heart Test. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 767.2 K | 563.6 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.